Edit |   |
---|---|
Antigenic Specificity | CD257, Human (Tabalumab biosimilar) |
Clone | Tabalumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FuncS, IF, Neut, ELISA, FCM, IP |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD257 Recombinant Antibody (Tabalumab). Tabalumab (LY 2127399) is an anti-B-cell activating factor (BAFF) human monoclonal antibody designed for the treatment of autoimmune diseases and B cell malignancies. Tabalumab was developed by Eli Lilly and Company. |
Immunogen | n/a |
Other Names | Anti-CD257 Recombinant Antibody, Research Grade Tabalumab, Anti-Human CD257 Recombinant Antibody(Tabalumab), LY2127399, Antibody Drug Analogues, Monoclonal Antibody, YR1262, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1143503-67-6 |
Catalog # | YR1262 |
Price | please inquire |
Order / More Info | CD257, Human (Tabalumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |